The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Case Report: A Rare Mimic of Giant Cell Arteritis

Case Report: A Rare Mimic of Giant Cell Arteritis

November 14, 2021 • By Iryna Nemesh, MD, Saleema Kherani, MD MPH, Shikha Singla, MD, & William Wirostko, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Spectral domain optical coherence tomography (SD-OCT) of the left eye with hyper-reflective retinal pigment epithelial (RPE) nodularity (white arrow) and overlying loss of normal photo receptor architecture.

Figure 2. Spectral domain optical coherence tomography (SD-OCT) of the left eye with hyper-reflective retinal pigment epithelial (RPE) nodularity (white arrow) and overlying loss of normal photo receptor architecture.

Discussion

Ocular syphilis is rare and tends to occur at any stage of the disease. However, it is commonly associated with neurosyphilis. Its incidence has been increasing in the developed countries for the past few years. This may be related in part to decreased condom use in high-risk populations following the advent of highly active anti-retroviral therapy (HAART).5

You Might Also Like
  • Giant Cell Arteritis
  • Permanent Vision Loss in Late Giant Cell Arteritis
  • Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges
Explore This Issue
November 2021

Because its clinical manifestations vary, ocular syphilis is a big masquerader and may be challenging to diagnose. Ocular symptoms are commonly non-specific and may lead to a delay in diagnosis and treatment. New-onset, monocular, blurry vision is usually an early manifestation; however, other non-specific systemic symptoms can mask the diagnosis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The clinical presentation of monocular vision changes when present with relevant associated symptoms can be concerning for GCA, which can lead to permanent visual loss if untreated. Therefore establishing a definitive diagnosis is paramount.

Elevated inflammatory markers may be present in both conditions. Patients with such a presentation are often empirically treated with high-dose systemic steroids and can be subjected to a temporal artery biopsy. Because the diagnostic yield of a temporal artery biopsy is low, these patients can remain on treatment despite a negative biopsy result. A diagnosis of ocular syphilis in such cases can be missed, resulting in permanent visual impairment. A timely diagnosis of this important clinical entity can mitigate unnecessary testing and prevent complications.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Based on our experience, we recommend testing for syphilis and tuberculosis prior to initiating systemic steroid therapy. Additionally, a detailed sexual history must be obtained, and those with high-risk behaviors must also be tested for syphilis.


Iryna Nemesh, MD, is a rheumatology fellow in the Department of Medicine, Division of Rheumatology, Medical College of Wisconsin Affiliated Hospitals, Milwaukee.

Saleema Kherani, MD, MPH, is an ophthalmology resident in the Department of Ophthalmology, Medical College of Wisconsin Affiliated Hospitals, Milwaukee.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Shikha Singla, MD, is an assistant professor in the Department of Medicine, Division of Rheumatology, Medical College of Wisconsin Affiliated Hospitals, Milwaukee.

William Wirostko, MD, is a professor of vitreoretinal surgery and ocular oncology in the Department of Ophthalmology, Medical College of Wisconsin Affiliated Hospitals, Milwaukee.

References

  1. Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: The new epidemic. Eye (Lond). 2006 Jun;20(6):703–705.
  2. Majumder PD, Chen EJ, Shah J, et al. Ocular syphilis: An update. Ocul Immunol Inflamm. 2019;27(1):117–125.
  3. Kiss S, Damico FM, Young LH. Ocular manifestations and treatment of syphilis. Semin Ophthalmol. 2005;20(3):161–167.
  4. Biousse V, Newman NJ. Ischemic optic neuropathies. N Engl J Med. 2015 Jun 18;372(25):2428–2436.
  5. Fonollosa A, Giralt J, Pelegrín L, et al. Ocular syphilis-back again: Understanding recent increases in the incidence of ocular syphilitic disease. Ocul Immunol Inflamm. 2009 May–Jun; 17(3):207–212.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Vasculitis Tagged With: ocular disease, syphilisIssue: November 2021

You Might Also Like:
  • Giant Cell Arteritis
  • Permanent Vision Loss in Late Giant Cell Arteritis
  • Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges
  • Race May Not Be a Risk Factor for Giant Cell Arteritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)